- Advertisement -
World

EU health regulator says Covid pandemic not over

It says it's important that member states prepare for the rollout of vaccines, especially the adaptive vaccines, to prevent further spread of the disease in Europe.

Reuters
2 minute read
Share
People walk through a pedestrian area in Cologne, western Germany on Jan 4, 2021 amid the ongoing Covid-19 pandemic. Photo: AFP
People walk through a pedestrian area in Cologne, western Germany on Jan 4, 2021 amid the ongoing Covid-19 pandemic. Photo: AFP

An official at the European Union's drugs regulator said on Tuesday the Covid-19 pandemic was not over, contradicting US President Joe Biden, and that a planned vaccination campaign in the region during the cold season was key to fighting it.

"We in Europe still consider the pandemic as ongoing and it's important that member states prepare for rollout of the vaccines and especially the adaptive vaccines to prevent further spread of this disease in Europe," the European Medicines Agency's (EMA) Chief Medical Officer Steffen Thirstrup told a media briefing, referring to vaccines targeting specific strains of the virus.

He was asked to comment on Biden's remark in an interview broadcast on Sunday that "the pandemic is over".

"I cannot obviously answer why President Biden came to that conclusion," Thirstrup said.

The World Health Organization has said the pandemic remains a global emergency but the end could be in sight if countries use the tools at their disposal.

During the media briefing, EMA officials reaffirmed a call by the agency's Executive Director Emer Cooke made last week in a Reuters Next Newsmaker interview that people in Europe should take whatever Covid-19 booster is available and recommended to them in the coming months. 

Apart from the original Covid vaccines, the EMA has in recent weeks endorsed a number of vaccines adapted to the Omicron variant of the virus for use as booster shots to ease the burden from a feared surge in infections during autumn and winter in Europe.

The EMA's head of vaccines strategy, Marco Cavaleri, said the agency was also looking into the use of the adapted shots as a primary course of vaccination and that there were discussions on the types of data that could support such an approval